Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls
Salivary levels of DMBT1 and CSTB may be accurate in diagnosing GCs.
»
04/30/22
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
EMSC exhibited distinct gene mutation frequencies and MSI, TMB and gLOH biomarker signatures.
»
09/27/21
Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01).
RARP patients reported earlier return to baseline in global health status.
»
02/15/22
Colorectal cancer develops inherent radiosensitivity that can be predicted using patient-derived organoids.
Broad radiation sensitivity occurs in large subset of patients.
»
04/22/22
GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
GSTM3 binds to Cullin-associated and neddylation-dissociated 1 protein (CAND1).
»
01/24/22
Alcohol metabolism genes and risks of site-specific cancers in Chinese adults: An 11-year prospective study.
Causal effects of alcohol consumption on upper aerodigestive tract cancers.
»
11/03/21
Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury.
Lobectomy caused significant reduction in postoperative soluble receptor levels.
»
11/07/20
Sodium accumulation in breast cancer predicts malignancy and treatment response.
Effective treatment with docetaxel reduced tumour Na+.
»
09/11/21
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.
NECTIN4-directed antibody-drug conjugates might be promising.
»
11/12/21
FGFR1 is a potential therapeutic target in neuroblastoma
N546K mutation caused failure in response to treatment with FGFR1 inhibitor.
»
04/29/22
< Prev
Next >